Delivery Order SPE2DB20D2104-SPE2DB24FMARU
Award Date
9/3/24
Potential Completion Date
9/4/24
Potential Value
$1.4K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $8,187.22, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Estrace 0.01% cream, a prescription medication, and does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA), a defense agency. The contract is for the delivery of Estrace 0.01% cream, a medication used for various medical conditions. The contract has a ceiling value of $1,237.72 and is a firm fixed price delivery order with a completion date of July 2, 2025. The contract is not set aside for any particular business type. Amerisourcebergen Drug Corp holds a...
This federal contract award is a delivery order (SPE2DB22D1017|SPE2DB24FF3AK) with a ceiling value of $2,415.00 issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Estrace 0.01% cream, a prescription medication, to support military healthcare programs. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that...
This is a Firm Fixed Price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,823.84, is for the delivery of Estrace 0.01% Cream, a pharmaceutical product used in medical care. The order has a performance period through July 15, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,739.91 firm fixed-price delivery order is for the supply of Estrace 0.01% cream, a topical estrogen medication, to support federal healthcare programs. The award is part of a broader $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which serves as a...
This contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order from the Defense Logistics Agency (DLA) Troop Support Medical for the pharmaceutical product Estrace 0.01% Cream, 42.5 grams. The contract has a ceiling value of $1,688.88 and a period of performance through March 3, 2022. This award is not designated as a set-aside contract. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award is for the delivery of Estrace 0.01% cream, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract, valued at $1,513.26, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on June 2, 2023. The contract has a completion date of June 5, 2023 and is a Firm Fixed Price Delivery Order. This award is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., holds...
The federal contract award SPE2DB20D3101|SPE2DB22FH4K7, valued at $1,670.63, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract involves the delivery of Estrace 0.01% cream, a medication used for various medical conditions. This contract award is a Delivery Order, with a Firm Fixed Price pricing type, and does not have a set-aside designation. Amerisourcebergen Drug Corp is a subsidiary of the parent company...
This federal contract award with ID SPE2DX15D3504|SPE2DX24F03L0 was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, which has a ceiling value of $1,199.21, is for the delivery of Estradiol 0.01% Cream in 42.5 gram units. This is a firm fixed-price delivery order contract with a final completion date of February 1, 2024. The contract does...
This contract award to AmerisourceBergen Drug Corp is for the delivery of Estradiol 0.01% cream, a pharmaceutical product, to support federal government healthcare programs. The $2,561.18 firm fixed-price delivery order was issued by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of August 7, 2023. The award is associated with a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA, valued at $999,999,999 and running through...